SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-143183
Filing Date
2017-04-27
Accepted
2017-04-27 16:43:05
Documents
8
Period of Report
2017-08-03
Effectiveness Date
2017-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d345608ddef14a.htm DEF 14A 297618
2 GRAPHIC g345608g11y77.jpg GRAPHIC 26592
3 GRAPHIC g345608g21j11.jpg GRAPHIC 24658
4 GRAPHIC g345608g44j11.jpg GRAPHIC 32373
5 GRAPHIC g345608g48k66.jpg GRAPHIC 28639
6 GRAPHIC g345608g56z83.jpg GRAPHIC 16586
7 GRAPHIC g345608g57f70.jpg GRAPHIC 22487
8 GRAPHIC g345608g70d41.jpg GRAPHIC 25648
  Complete submission text file 0001193125-17-143183.txt   543089
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: DEF 14A | Act: 34 | File No.: 001-37695 | Film No.: 17789748
SIC: 2834 Pharmaceutical Preparations